Wang S P, Zhou H J, Chen X P, Ren G Y, Ruan X X, Zhang Y, Zhang R L, Chen J
Center of Hepatic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, PR China.
J Exp Clin Cancer Res. 2007 Mar;26(1):117-24.
KLF6 (Zf9, COPEB), an ubiquitous transcription factor, maps to chromosome 10p. Recently, KLF6 was found to have a more generalized role in tumorigenesis as a candidate tumor suppressor gene for some tumors. However, results from other published studies seem not to be in agreement with data from previous studies. Gene-expression analysis is increasingly important in biological research. Loss of expression is one of the mechanisms to functionally inactivate a tumor suppressor gene. To investigate the expression change of KLF6 gene associated with HCC as a step toward a better understanding of the molecular pathophysiology, and to provide the basis for analysis of KLF6 gene in HCC carcinogenesis. We analyzed the expression of KLF6 mRNA in 26 samples of HCC tissues and hepatoma cell lines(Hep3B and HepG2) detected by Real-Time quantitative RT-PCR (qRT-PCR) and conventional RT-PCR assay. To confirm and extend the data obtained at RNA level, we performed detailed immunoblotting analysis on HCC tissues and hepatoma cell lines using a rabbit polyclonal antibody specific for KLF6. NKLF6 detected by qRT-PCR from HCC and corresponding noncancerous tissues was 0.04+/-0.038 and 0.116+/-0.101, respectively. These data demonstrated that KLF6 mRNA level was significantly decreased in HCC, compared with corresponding noncancerous tissues (t =3.683 , P<0.001). The frequency of Hepatoma Cell Lines with KLF6 down-regulation detected by conventional PT-PCR, seems to be consistent with a previous study using real-time PCR assays in tumor samples. KLF6 expression levels were determined by Western blot. Compared to the matched surrounding tissues, a clear decrease of KLF6 protein levels in tumor tissues was observable (t=13.59, P<0.001). Hepatoma cell lines also showed low-level of KLF6 protein (P<0.01) expression. Immunohistochemistry and immunocytochemistry showed a faint diffused staining in the HCC tissues and hepatoma cell lines, and endogenous KLF6 protein was detected mostly in the cytoplasm. KLF6 gene appeared markedly reduced in HCC tissues and hepatoma cell lines. Frequent down-regulation of KLF6 strongly suggested that it is a candidate of tumor suppressor gene for HCC.
KLF6(Zf9,COPEB)是一种普遍存在的转录因子,定位于染色体10p。最近,KLF6被发现作为某些肿瘤的候选抑癌基因在肿瘤发生中具有更广泛的作用。然而,其他已发表研究的结果似乎与先前研究的数据不一致。基因表达分析在生物学研究中越来越重要。表达缺失是使抑癌基因功能失活的机制之一。为了研究与肝癌相关的KLF6基因的表达变化,以更好地理解分子病理生理学,并为分析KLF6基因在肝癌发生中的作用提供依据。我们通过实时定量逆转录聚合酶链反应(qRT-PCR)和传统逆转录聚合酶链反应(RT-PCR)分析了26例肝癌组织样本及肝癌细胞系(Hep3B和HepG2)中KLF6 mRNA的表达。为了证实并扩展在RNA水平获得的数据,我们使用针对KLF6的兔多克隆抗体对肝癌组织和肝癌细胞系进行了详细的免疫印迹分析。通过qRT-PCR检测肝癌组织及相应癌旁组织中的NKLF6分别为0.04±0.038和0.116±0.101。这些数据表明,与相应癌旁组织相比,肝癌组织中KLF6 mRNA水平显著降低(t = 3.683,P < 0.001)。通过传统RT-PCR检测到KLF6下调的肝癌细胞系频率,似乎与先前在肿瘤样本中使用实时PCR分析的研究结果一致。通过蛋白质免疫印迹法测定KLF6表达水平。与匹配的周围组织相比,肿瘤组织中KLF6蛋白水平明显降低(t = 13.59,P < 0.001)。肝癌细胞系也显示出低水平的KLF6蛋白(P < 0.01)表达。免疫组织化学和免疫细胞化学显示肝癌组织和肝癌细胞系中有微弱的弥漫性染色,内源性KLF6蛋白大多在细胞质中检测到。KLF6基因在肝癌组织和肝癌细胞系中明显减少。KLF6的频繁下调强烈表明它是肝癌的候选抑癌基因。